Mobile Insulin Titration Intervention
NCT01879579 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 61
Last updated 2015-10-12
Summary
The purpose of this pilot study is to determine whether text message (and phone) communication can be effectively utilized to adjust long-acting insulin, compared to standard practice.
Conditions
Interventions
- OTHER
-
Mobile Insulin Titration Intervention
Patients send their fasting blood glucose levels to the clinic diabetes nurses via text message each weekday. The diabetes nurses call each patient once a week to give insulin titration instructions to replace in-person clinic visits for insulin titration.
Sponsors & Collaborators
-
New York City Health and Hospitals Corporation
collaborator OTHER - lead OTHER
Principal Investigators
-
Natalie Levy, MD · NYU Langone Health
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-06-30
- Primary Completion
- 2015-03-31
- Completion
- 2015-06-30
Countries
- United States
Study Locations
More Related Trials
-
An Inpatient Performance Evaluation of a New Subcutaneous Glucose Sensor
NCT01112696 ·Status: COMPLETED ·Phase: NA
-
Feasibility Study Assessing The Ability Of An Insulin Pump-Controlling Algorithm To Minimize Hypoglycemia And Hyperglycemia In Patients With Type 1 Diabetes In A Clinical Research Setting
NCT01401751 ·Status: COMPLETED ·Phase: NA
-
Integrating Insulin Delivery and Glucose Sensing in Subcutaneous Tissue for the Treatment of Type-1 Diabetic Patients
NCT00812591 ·Status: COMPLETED ·Phase: NA
-
Web-based Insulin Titration - An Efficacy Study
NCT01715090 ·Status: COMPLETED ·Phase: NA
-
Timing of Insulin Before Meals Everyday
NCT00789945 ·Status: TERMINATED ·Phase: NA
-
Insulin Degludec Titration Using Mobile Insulin Dosing System
NCT03091712 ·Status: COMPLETED ·Phase: NA
-
Glucose Counterregulation in Long Standing Type 1 Diabetes
NCT01474889 ·Status: COMPLETED ·Phase: NA
-
Closed-loop Glucose Control for Automated Management of Type 1 Diabetes
NCT00811317 ·Status: COMPLETED ·Phase: NA
-
Feasibility Study of an Integrated Sensor and Infusion Set
NCT01770561 ·Status: COMPLETED ·Phase: NA
-
Suspending Basal Insulin Levels for Exercise in Adults With Type 1 Diabetes
NCT03034798 ·Status: COMPLETED
-
Hypoglycemia Prevention After Exercise in Adolescent T1DM Patients Using a Control to Range System
NCT01390259 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of 7-day Wear Infusion Set vs. Control Infusion Set.
NCT04208282 ·Status: COMPLETED ·Phase: NA
-
Closed-loop Control of Glucose Levels in the Context of Exercise in Adults With Type-1 Diabetes
NCT01297946 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
CGM Intervention in Teens and Young Adults With Type 1 Diabetes (T1D)
NCT03263494 ·Status: COMPLETED ·Phase: PHASE3
-
Effect of Closed Loop Glucose Control on Exercise-Associated Hypoglycemia
NCT00831389 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Extended Infusion Set Wear Using Medtronic Extended Wear Sof-set Infusion Set
NCT02687256 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of RT-CGMS in Patients With Type 1 Diabetes Mellitus Treated With an Implantable Pump
NCT00501072 ·Status: COMPLETED ·Phase: NA
-
Comparison of Two Titration Programs of Adding Insulin Detemir to OADs in Poorly Controlled Type 2 Diabetes
NCT01281605 ·Status: COMPLETED ·Phase: NA
-
Flexible, Intensive Insulin Therapy in Patients With Type 1 Diabetes
NCT00595569 ·Status: COMPLETED
-
Sensor and Software Use for Improved Glucose Control in MDI Managed Diabetes
NCT01713348 ·Status: COMPLETED ·Phase: PHASE4
-
Effectiveness and Safety Study of the DexCom™ G4 Continuous Glucose Monitoring System in Children and Adolescents With Type 1 Diabetes Mellitus
NCT01185496 ·Status: COMPLETED
-
The Steno Opti-Bolus-Timing Studies
NCT07021690 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Real-time Adaptation to Changes in Insulin Sensitivity
NCT01261052 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of LY900014 and Insulin Degludec in Participants With Type 1 Diabetes
NCT04585776 ·Status: COMPLETED ·Phase: PHASE2
-
Optimal Insulin Correction Factor in Post- High Intensity Exercise Hyperglycemia in Adults With Type 1 Diabetes (FIT)
NCT03057470 ·Status: UNKNOWN ·Phase: PHASE4